Is Gilead Sciences, Inc. (NASDAQ: GILD) Back In The Buying Zone?
Capital Research & Management Co recently announced the acquisition of new stake in Gilead Sciences, Inc. (NASDAQ:GILD). The institutional investor has increased its shareholding in the Healthcare company by 0.98% to 81.72 million shares with purchase of 0.79 million shares. This fresh investment now brings its stake to 6.56% valued currently at $6.62 billion. In […]
Gilead Sciences, Inc. (NASDAQ: GILD) Hogging The Spotlight Today
Capital Research & Management Co recently announced the acquisition of new stake in Gilead Sciences, Inc. (NASDAQ:GILD). The institutional investor has increased its shareholding in the Healthcare company by 0.98% to 81.72 million shares with purchase of 0.79 million shares. This fresh investment now brings its stake to 6.56% valued currently at $6.62 billion. In […]
Gains May Be On The Menu For Gilead Sciences, Inc. (NASDAQ: GILD)
Capital Research & Management Co recently announced the acquisition of new stake in Gilead Sciences, Inc. (NASDAQ:GILD). The institutional investor has increased its shareholding in the Healthcare company by 0.98% to 81.72 million shares with purchase of 0.79 million shares. This fresh investment now brings its stake to 6.56% valued currently at $6.26 billion. In […]
Gilead Sciences, Inc. (NASDAQ: GILD) – Not A Clear Buying Opportunity?
Capital Research & Management Co has recently announced that it has increased stake in Gilead Sciences, Inc. (NASDAQ:GILD) by 0.98%. After grabbing 81.72 million shares, the institutional investor is now in possession of 0.79 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.56% having worth around $6.26 […]
Handle With Care: Gilead Sciences, Inc. (NASDAQ: GILD)
Capital Research & Management Co recently announced the acquisition of new stake in Gilead Sciences, Inc. (NASDAQ:GILD). The institutional investor has increased its shareholding in the Healthcare company by 0.98% to 81.72 million shares with purchase of 0.79 million shares. This fresh investment now brings its stake to 6.56% valued currently at $6.26 billion. In […]
